HR 1193 117th Congress

Cardiovascular Advances in Research and Opportunities Legacy Act

Latest Action

Became Public Law No: 117-244.

Congress.gov

Sponsors

Rep. Barr, Andy [R-KY-6]

Rep. Barr, Andy [R-KY-6]

R — KY

Summary

Cardiovascular Advances in Research and Opportunities Legacy Act This act addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health may conduct or support research on the disease in consultation with the National Heart, Lung, and Blood Institute (NHLBI). The NHLBI must also conduct a workshop on mitral valve prolapse, which occurs when the valve between the chambers of the left side of the heart seals improperly. The Department of Health and Human Services (HHS) must develop best practices to treat valvular heart disease. HHS may also carry out other projects to increase education and awareness of the disease.
Cardiovascular Advances in Research and Opportunities Legacy Act This bill addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health may conduct or support research on the disease in consultation with the National Heart, Lung, and Blood Institute (NHLBI). The NHLBI must also conduct a workshop on mitral valve prolapse, which occurs when the valve between the chambers of the left side of the heart seals improperly. The Department of Health and Human Services (HHS) must develop best practices to treat valvular heart disease. HHS may also carry out other projects to increase education and awareness of the disease.
Cardiovascular Advances in Research and Opportunities Legacy Act This bill addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health may conduct or support research on the disease in consultation with the National Heart, Lung, and Blood Institute (NHLBI). The NHLBI must also conduct a workshop on mitral valve prolapse, which occurs when the valve between the chambers of the left side of the heart seals improperly. The Department of Health and Human Services (HHS) must develop best practices to treat valvular heart disease. HHS may also carry out other projects to increase education and awareness of the disease.
Cardiovascular Advances in Research and Opportunities Legacy Act This bill addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health may conduct or support research on the disease in consultation with the National Heart, Lung, and Blood Institute (NHLBI). The NHLBI must also conduct a workshop on mitral valve prolapse, which occurs when the valve between the chambers of the left side of the heart seals improperly. The Department of Health and Human Services (HHS) must develop best practices to treat valvular heart disease. HHS may also carry out other projects to increase education and awareness of the disease.
Cardiovascular Advances in Research and Opportunities Legacy Act This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly. The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.
Cardiovascular Advances in Research and Opportunities Legacy Act This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly. The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.

Actions

2022-12-20T00:00:00

Became Public Law No: 117-244.

2022-12-20T00:00:00

Became Public Law No: 117-244.

2022-12-20T00:00:00

Signed by President.

2022-12-20T00:00:00

Signed by President.

2022-12-16T00:00:00

Presented to President.

2022-12-16T00:00:00

Presented to President.

2022-12-05T00:00:00

Motion to reconsider laid on the table Agreed to without objection.

2022-12-05T00:00:00

On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H8755)

2022-12-05T00:00:00

Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote.

2022-12-05T00:00:00

DEBATE - The House proceeded with forty minutes of debate on the Senate amendment to H.R. 1193.

2022-12-05T00:00:00

Mr. Pallone moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H8755-8756)

2022-12-05T00:00:00

Message on Senate action sent to the House.

2022-12-01T00:00:00

Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S6947)

2022-12-01T00:00:00

Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S6947)

2022-12-01T00:00:00

The committee substitute withdrawn by Unanimous Consent.

2022-12-01T00:00:00

Measure laid before Senate by unanimous consent. (consideration: CR S6946-6947)

2022-07-12T00:00:00

Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.

2022-07-12T00:00:00

Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.

2022-07-12T00:00:00

Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.

2022-06-14T00:00:00

Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.

2022-05-25T00:00:00

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2021-12-09T00:00:00

Received in the Senate.

2021-12-08T00:00:00

The title of the measure was amended. Agreed to without objection.

2021-12-08T00:00:00

Motion to reconsider laid on the table Agreed to without objection.

2021-12-08T00:00:00

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7518)

2021-12-08T00:00:00

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7518)

2021-12-08T00:00:00

DEBATE - The House proceeded with forty minutes of debate on H.R. 1193.

2021-12-08T00:00:00

Considered under suspension of the rules. (consideration: CR H7518-7522)

2021-12-08T00:00:00

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

2021-12-08T00:00:00

Placed on the Union Calendar, Calendar No. 153.

2021-12-08T00:00:00

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-212.

2021-12-08T00:00:00

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-212.

2021-11-17T00:00:00

Ordered to be Reported (Amended) by Voice Vote.

2021-11-17T00:00:00

Committee Consideration and Mark-up Session Held.

2021-11-04T00:00:00

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

2021-11-04T00:00:00

Subcommittee Consideration and Mark-up Session Held.

2021-02-23T00:00:00

Referred to the Subcommittee on Health.

2021-02-22T00:00:00

Referred to the House Committee on Energy and Commerce.

2021-02-22T00:00:00

Introduced in House

2021-02-22T00:00:00

Introduced in House

Policy Areas

Health

Track this bill on CivicBeacon

Get push notifications when this bill is updated, contact your reps, and take action.

Download on the App Store Get it on Google Play